All Stories

  1. The direct deleterious effect of Th17 cells in the nervous system compartment in multiple sclerosis and experimental autoimmune encephalomyelitis: one possible link between neuroinflammation and neurodegeneration

    Article • Revista Romana de Medicina de Laborator, January 2020, De Gruyter

    Dr Smaranda Maria Maier

  2. Clinical and Serological Biomarkers of Treatment’s Response in Multiple Sclerosis Patients Treated Continuously with Interferonβ-1b for More than a Decade

    Article • CNS & Neurological Disorders - Drug Targets, November 2018, Bentham Science Publishers

    Dr Smaranda Maria Maier, Zoltán Bajko , Adina Hutanu, Rodica Balasa

  3. The Matrix Metalloproteinases Panel in Multiple Sclerosis Patients Treated with Natalizumab: A Possible Answer to Natalizumab Non- Responders

    Article • CNS & Neurological Disorders - Drug Targets, August 2018, Bentham Science Publishers

    Adina Hutanu, Dr Smaranda Maria Maier, Bianca Emilia Ciurba, Septimiu Voidazan

  4. Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action

    Article • CNS & Neurological Disorders - Drug Targets, January 2018, Bentham Science Publishers

    Dr Smaranda Maria Maier, Adina Hutanu, Rodica Balasa, Mihaela Adriana Simu, Zoltán Bajko

  5. Plasma phosphorylated neurofilament heavy chains as a potential marker for ischemic stroke patients

    Article • Revista Romana de Medicina de Laborator, January 2018, De Gruyter

    Dr Smaranda Maria Maier

  6. Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response

    Article • CNS & Neurological Disorders - Drug Targets, January 2017, Bentham Science Publishers

    Dr Smaranda Maria Maier

  7. An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β

    Article • CNS & Neurological Disorders - Drug Targets, June 2015, Bentham Science Publishers

    Dr Smaranda Maria Maier